ENTITY
BeOne Medicines

BeOne Medicines (6160 HK)

502
Analysis
Health Care • Switzerland
BeOne Medicines is a global oncology biotechnology company focused on the discovery, development, and commercialization of cancer medicines. Its portfolio includes commercial-stage products like BRUKINSA, TEVIMBRA, and PARTRUVIX, which target various blood cancers and solid tumors. The company was founded in 2010 and is headquartered in Basel, Switzerland.
more
Exchange Announcement • 06 Oct 2026 17:19

Grant Of Restricted Share Units

Exchange Announcement • 14 Sep 2026 16:56

Share Purchase Pursuant To The Employee Share Purchase Plan

Exchange Announcement • 10 Sep 2026 16:42

Reminder Letter And Reply Form To Non-Registered Shareholders - Arrangement Of Electronic Dissemination Of Corporate Communications

Exchange Announcement • 10 Sep 2026 16:37

Reminder Letter And Reply Form To Registered Shareholders - Arrangement Of Electronic Dissemination Of Corporate Communications

Exchange Announcement • 10 Sep 2026 16:30

2026 Interim Report

x